. Author manuscript; available in PMC: 2018 Jun 18.

Published in final edited form as: Innate Immun. 2014 Dec 23;21(5):553–561. doi: 10.1177/1753425914564609

Table 1.

BCG-infected BMDCs cultured with or without recombinant human (hLF) or mouse LF (mLF) examined for cytokines involved in regulating MTB infection.

DCs	Non-infected	hLF	mLF	BCG	BCG + hLF	BCG + mLF
TNF-α	20 ± 11	10 ± 3	11 ± 4	946 ± 202	965 ± 192	969 ± 275
IL-6	11 ± 4	10 ± 5	11 ± 4	1166 ± 162	1139 ± 132	1159 ± 172
IL-1β	0.7 ± 0.7	0.6 ± 0.5	0.8 ± 0.8	208 ± 246	261 ± 297	315 ± 336
IL-12p40	14 ± 17	6 ± 9	7 ± 9	841 ± 349	844 ± 373	966 ± 484
IL-10	6 ± 6	7 ± 6	6 ± 5	196 ± 104	226 ± 110	211 ± 108

BCG infected BMDCs cultured with or without recombinant human or mouse LF examined for cytokines involved in regulating MTB infection. Values given are in pg/ml and reported as mean ± standard deviation. Significant changes relative to BCG alone are shaded in grey; significant at p<0.05 using an unpaired Student T-test. Non-infected BMDCs, or control LF incubated cells, did not produce levels above background.